The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

Gut

Volumn 59, Issue 2, 2010, Pages 197-206

  Vetrano, Stefania ^a   Borroni, Elena M ^b   Sarukhan, Adelaida ^b   Savino, Benedetta ^b   Bonecchi, Raffaella ^b   Correale, Carmen ^a   Arena, Vincenzo ^c   Fantini, Massimo ^d   Roncalli, Massimo ^b   Malesci, Alberto ^a,b   Mantovani, Alberto ^b   Locati, Massimo ^b   Danese, Silvio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CHEMOKINE; DECOY RECEPTOR D6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHIMERA; COLITIS; COLON CANCER; COLON MUCOSA; COMPARATIVE STUDY; CONTROLLED STUDY; DESCENDING COLON; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENTERITIS; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; LEUKOCYTE; LYMPH VESSEL; LYMPHATIC SYSTEM; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR PROMOTION; WILD TYPE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; COLONOSCOPY; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LEUKOCYTES; LYMPHATIC VESSELS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; RECEPTORS, CCR10;

EID: 77149126406     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.183772     Document Type: Article

References (38)

1. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
2. Rollins BJ. Chemokines. Blood 1997;90:909-28.
3. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 1999;20:254-7.
4. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108-15.
5. Bottazzi B, Polentarutti N, Acero R, et al. Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983;220:210-12.
6. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-50.
7. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008;454:436-44.
8. Kelvin DJ, Michiel DF, Johnston JA, et al. Chemokines and serpentines: the molecular biology of chemokine receptors. J Leukoc Biol 1993;54:604-12.
9. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994;12:593-633.
10. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52:145-76.
11. Mantovani A, Locati M, Vecchi A, et al. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 2001;22:328-36.
12. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001;158:867-77.
13. Nibbs RJ, Wylie SM, Yang J, et al. Cloning and characterisation of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem 1997;272:32078-83.
14. Bonecchi R, Locati M, Galliera E, et al. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol 2004;172:4972-6.
15. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006;6:907-18.
16. Martinez de la Torre Y, Buracchi C, Borroni EM, et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A 2007;104:2319-24.
17. Locati M, Torre YM, Galliera E, et al. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines. Cytokine Growth Factor Rev 2005;16:679-86.
18. Danese S, Gasbarrini A. Chemokines in inflammatory bowel disease. J Clin Pathol 2005;58:1025-7.
19. Fantini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 2008;9:375-80.
20. Jamieson T, Cook DN, Nibbs RJ, et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 2005;6:403-11.
21. Ajuebor MN, Hogaboam CM, Kunkel SL, et al. The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol 2001;166:552.
22. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
23. Vetrano S, Rescigno M, Cera MR, et al. Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 2008;135:173-84.
24. Mantovani A. Cancer: inflammation by remote control. Nature 2005;435:752-3.
25. Mantovani A. Cancer: an infernal triangle. Nature 2007;448:547-8.
26. Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005;307:1904-9.
27. Locati M, Otero K, Schioppa T, et al. The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses. Allergy 2002;57:972-82.
28. Fantini MC, Becker C, Neurath MF. Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy. Expert Rev Anticancer Ther 2005;5:681-94.
29. Martinez de la Torre Y, Locati M, Buracchi C, et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol 2005;35:1342-6.
30. Locati M, Deuschle U, Massardi ML, et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 2002;168:3557-62.
31. Graham GJ, McKimmie CS. Chemokine scavenging by D6: a movable feast? Trends Immunol 2006;27:381-6.
32. Di LD, Locati M, Caccamo N, et al. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J Exp Med 2008;205:2075-84.
33. McKimmie CS, Fraser AR, Hansell C, et al. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol 2008;181:8171-81.
34. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
35. Mantovani A, Allavena P, Sozzani S, et al. Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol 2004;14:155-60.
36. Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002;2:106-15.
37. Nibbs RJ, Gilchrist DS, King V, et al. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest 2007;117:1884-92.
38. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007;317:124-39.